<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref22">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ogita</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Kubo</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Nishiyama</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Watanabe</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Nagashima</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Yoneda</surname>
    <given-names>Y.</given-names>
   </name>
  </person-group> (
  <year>2004</year>). 
  <article-title>Enhanced binding activity of nuclear antioxidant-response element through possible formation of Nrf2/Fos-B complex after in vivo treatment with kainate in murine hippocampus</article-title>. 
  <source>Neuropharmacology</source>
  <volume>46</volume>, 
  <fpage>580</fpage>â€“
  <lpage>589</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.neuropharm.2003.11.002</pub-id>, PMID: 
  <?supplied-pmid 14975682?>
  <pub-id pub-id-type="pmid">14975682</pub-id>
 </mixed-citation>
</ref>
